Key result
Intravenous iloprost added to standard therapy successfully accelerated renal function recovery in two cases of acute post-kidney transplant cholesterol embolization.
Why the study?
Cholesterol embolization is a serious post-transplant complication with unproven efficacy for statin and steroid therapy, while prostaglandin I2 agonism has shown benefit in systemic cases.
Does iloprost improve renal function in patients with acute post-kidney transplant cholesterol embolization?
Case Report (n=2)
No
Does iloprost improve renal function in patients with acute post-kidney transplant cholesterol embolization?
Iloprost added to statins and steroids may accelerate recovery of renal function in acute post-kidney transplant cholesterol embolization.
Answers are grounded in this paper and cite their sources.
May support iloprost in post-transplant CE; hypothesis-generating and leaves open need for controlled trials.
Cholesterol embolization (CE) is a rare and fearsome post transplant complication, responsible of primary non function (PNF) or delayed graft function (DGF), whose incidence is expected to increase since the older age of donor and recipients and extended criteria donation. Therapy with statins and steroids is not of proved efficacy. Agonism of prostaglandin I2 has been reported as useful in systemic CE. We report two cases of acute post transplant CE in which iloprost (0,05 mg/kg/die) has been added to statin and steroid therapy. CE was due in the first case to embolization from the kidney artery and produced embolization in small vessels, after long DGF and 15 days of iloprost therapy renal function recovered. The second is the case of embolization from the iliac artery of the recipient where CE manifested as partial renal infarction. After 5 days of iloprost creatinine improved. Iloprost acts on vasodilation and on different pathways of inflammation improving anti-inflammatory profile. Post-transplant CE is difficult to diagnose and, if not treated, can lead to loss of function. Iloprost could help in accelerating recovery of function
No takes yet. Share an insight, caveat, or question.
Corradetti et al. (2020) conducted a case report in Acute post-kidney transplant atheroembolism (n=2). Iloprost was evaluated on Recovery of kidney function (creatinine levels). Intravenous iloprost added to standard therapy successfully accelerated renal function recovery in two cases of acute post-kidney transplant cholesterol embolization.
Synapse has enriched 10 related papers. Consider them for comparative context: